We are live on
!
Find out more
PCM
Pentwater Capital Management Portfolio holdings
AUM
$19.3B
1-Year Est. Return
58.13%
This Fund
S&P 500
This Quarter
Est. Return
-0.32%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$6.4B
AUM Growth
-$2.91B
(-31%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-43.38%
Top 10 Holdings %
Top 10 Hldgs %
64.6%
Holding
239
New
57
Increased
26
Reduced
57
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$264M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$133M |
| 3 |
PG&E
PCG
|
+$60.6M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$55.8M |
| 5 |
Philip Morris
PM
|
+$43.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$619M |
| 2 |
AGN
Allergan plc
AGN
|
+$582M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$457M |
| 4 |
NXP Semiconductors
NXPI
|
+$223M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.92% |
| 2 | Technology | 7.16% |
| 3 | Industrials | 2.45% |
| 4 | Consumer Discretionary | 2.31% |
| 5 | Materials | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVB
151
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $137K | ﹤0.01% |
+20,000
| New | +$202K |
|
|
BPL
152
DELISTED
Buckeye Partners, L.P.
BPL
| $5K | ﹤0.01% |
+125
| New | +$5.16K |
|
|
AGFSW
153
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
| $1K | ﹤0.01% |
242,331
| – | – |
|
154
PUT
Apple
AAPL
$4.56T
| – | – |
-50,000
| Closed | -$2.47M |
|
155
PUT
AbbVie
ABBV
$431B
| – | – |
-50,000
| Closed | -$3.64M |
|
156
Adaptive Biotechnologies
ADPT
$3.75B
| – | – |
-6,000
| Closed | -$290K |
|
157
Assurant
AIZ
$14.7B
| – | – |
-15,000
| Closed | -$1.6M |
|
158
Amalgamated Financial
AMAL
$1.5B
| – | – |
-33,897
| Closed | -$592K |
|
159
PUT
Amazon
AMZN
$2.94T
| – | – |
-40,000
| Closed | -$3.79M |
|
160
AtriCure
ATRC
$2.01B
| – | – |
-40,000
| Closed | -$1.19M |
|
161
Boeing
BA
$184B
| – | – |
-258,400
| Closed | -$92.4M |
|
|
162
PUT
Boeing
BA
$184B
| – | – |
-162,500
| Closed | -$59.2M |
|
163
CALL
Alibaba
BABA
$304B
| – | – |
-59,200
| Closed | -$10M |
|
164
CALL
Bunge Global
BG
$20.9B
| – | – |
-30,000
| Closed | -$1.67M |
|
165
BlackLine
BL
$1.74B
| – | – |
-15,000
| Closed | -$803K |
|
166
PUT
Bristol-Myers Squibb
BMY
$131B
| – | – |
-300,000
| Closed | -$13.6M |
|
167
Box
BOX
$4.41B
| – | – |
-7,500
| Closed | -$132K |
|
168
CALL
Centene
CNC
$31.7B
| – | – |
-1,045,800
| Closed | -$54.8M |
|
|
169
Centene
CNC
$31.7B
| – | – |
-31,843
| Closed | -$1.67M |
|
|
170
PUT
Centene
CNC
$31.7B
| – | – |
-1,150,000
| Closed | -$60.3M |
|
171
PUT
Coty
COTY
$2.39B
| – | – |
-200,000
| Closed | -$2.68M |
|
172
CrowdStrike
CRWD
$211B
| – | – |
-20,000
| Closed | -$341K |
|
173
CALL
CVS Health
CVS
$123B
| – | – |
-7,200
| Closed | -$392K |
|
|
174
CVS Health
CVS
$123B
| – | – |
-7,200
| Closed | -$392K |
|
175
Caesars Entertainment
CZR
$6.12B
| – | – |
-552,646
| Closed | -$25.5M |
|
Similar funds
CS
A
LF
MIM
SPIA
BPA
NAM
Pentwater Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Pentwater Capital Management held 239 positions worth $6.4B, down 31% from $9.31B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Pentwater Capital Management withdrew a net $2.77B in Q3 2019, closing 84 positions and reducing 57 holdings. Its most notable exit was Anadarko Petroleum, an estimated $619M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.
Against the trend, Pentwater Capital Management opened a new position in Viacom Inc. Class B worth $48.1M.
- Pentwater Capital Management's largest Q3 2019 buy was Viacom Inc. Class B: 2,000,100 shares worth $48.1M.
- Pentwater Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $264M increase.
- Pentwater Capital Management's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $582M.
- Pentwater Capital Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $619M.
- Pentwater Capital Management's ten largest holdings make up 65% of its $6.4B portfolio in Q3 2019.
- Pentwater Capital Management opened 57 new positions and closed 84 in Q3 2019.
- Pentwater Capital Management's portfolio value fell 31% quarter-over-quarter to $6.4B.
Based on Pentwater Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.